Profile Main business activities consist of laboratory through pilot plant syntheses of new molecular entities or developing new or modified production processes. An important part of this activity consists of developing laboratory procedures which are technically feasible, safe and environmentally acceptable. Many of the products which Niels Clauson-Kaas A/S develops are advanced stage intermediates and active pharmaceutical ingredients (APIs) for pre-clinical or clinical trials produced in compliance with cGMPs.